8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
People assigned to a diet, food or program and measured.
2016 / Randomized crossover trial
In two crossover trials, 32 children aged 11 to 13 years consumed five carbohydrate sides alongside beef. Children ate 30% to 40% fewer calories when consuming boiled and mashed potatoes compared with pasta, rice, or french fries (P<0.0001). Satiety per kilocalorie was highest with boiled and mashed potatoes (P<0.0001), while fried french fries resulted in the lowest glucose, insulin, and peptide YY concentrations (P<0.0001).
Akilen R, Deljoomanesh N, Hunschede S, et al. Nutr Diabetes, 2016. PMID 26878318
2016 / Randomized, double-blind, placebo-controlled trial
In this trial, 110 subjects with NAFLD were randomly assigned to receive either two garlic tablets daily (containing 400 mg of garlic powder) or placebo tablets. The intervention group demonstrated significant reductions in body weight and body fat mass (P < 0.05). Percentage change in body weight was significantly greater in the intervention group compared to the control group (-2.6 vs. -0.7, P = 0.02). Neither group showed significant changes in total body water or lean body mass (P > 0.05), and no serious side effects were reported.
Soleimani D, Paknahad Z, Askari G, et al. Adv Biomed Res, 2016. PMID 26955623
2016 / Randomized controlled trial
In an open-label trial with 50 adults having non-alcoholic fatty liver disease, participants received either lifestyle changes alone or with 30 grams daily of milled flaxseed for 12 weeks. Both groups improved, but flaxseed produced greater reductions in ALT (-11.12 vs -3.7 U/L), AST (-8.29 vs -4 U/L), GGT (-15.7 vs -2.62 U/L), fibrosis (-1.26 vs -0.77 kPa), and steatosis (-47 vs -15.45 dB/m). Body weight and insulin resistance also decreased more with flaxseed.
Yari Z, Rahimlou M, Eslamparast T, et al. Int J Food Sci Nutr, 2016. PMID 26983396
2016 / Randomized crossover trial
In a randomized crossover study, healthy young adults consumed evening meals of whole grain rye kernel bread (RKB) or white wheat bread (WWB) as either a single meal or across three consecutive evenings. Compared to WWB, the RKB evening meal decreased blood glucose (0-120 min, P = 0.001), serum insulin response (0-120 min, P < 0.05), and fasting free fatty acids (P < 0.05) the next morning. RKB also increased plasma PYY (0-120 min, P < 0.001), GLP-1 (0-90 min, P < 0.05), fasting acetate and butyrate (P < 0.05), breath hydrogen excretion (P < 0.001), and improved subjective appetite ratings (P < 0.05). With the exception of serum CRP, length of priming did not significantly alter outcomes.
Sandberg JC, Björck IM, Nilsson AC PLoS One, 2016. PMID 26990559
2016 / Multicenter randomized controlled trial
Healthy, non-obese participants were randomized 2:1 to 25% caloric restriction or an ad-libitum diet for two years. Overall adverse event rates did not differ significantly between arms, with zero deaths and one serious adverse event reported during caloric restriction. However, participants assigned to caloric restriction developed significantly lower bone mineral density at the lumbar spine, total hip, and femoral neck at 12 and 24 months.
Romashkan SV, Das SK, Villareal DT, et al. Oncotarget, 2016. PMID 26992237
2016 / Clinical trial
Thirty adults with type 2 diabetes followed an eight-week very low-calorie diet before returning to an isocaloric maintenance plan. Body weight dropped from 98.0 ± 2.6 to 83.8 ± 2.4 kg and remained stable at 84.7 ± 2.5 kg at six months. Fasting blood glucose normalized below 7 mmol/L in 12 participants after refeeding and in 13 participants at six months, accompanied by recovered first-phase insulin response.
Steven S, Hollingsworth KG, Al-Mrabeh A, et al. Diabetes Care, 2016. PMID 27002059
2016 / Pilot nutritional intervention
In a pilot nutritional intervention, 25 healthy subjects (mean age 38.3) consumed 12 Nocellara del Belice green table olives daily for 30 days. Results showed a significant variation in malondialdehyde and a significant decrease in interleukin-6 levels. Additionally, a reduction of fat mass with an increase of muscle mass was observed, whereas no statistically significant differences were found in fecal Lactobacilli concentrations despite a trend toward an increase. The authors caution that these preliminary findings must be verified in a larger sample.
Accardi G, Aiello A, Gargano V, et al. Immun Ageing, 2016. PMID 27053940
2016 / Randomized placebo-controlled trial
Researchers evaluated a four-ingredient nutritional mixture (GSK2890457) in rodent models and a six-week randomized trial with healthy participants and adults with type 2 diabetes. In diabetic participants taking liraglutide, the supplement did not lower weight and produced slight decreases in mean glucose and HbA1c compared to placebo. In those taking metformin, weight increased by 1.26%, while mean glucose and HbA1c were decreased slightly versus placebo.
Hodge RJ, Paulik MA, Walker A, et al. PLoS One, 2016. PMID 27093610
2016 / Multicenter randomized controlled trial
In a multisite trial, 218 healthy nonobese adults were randomized to 2 years of 25% calorie restriction or ad libitum intake. The calorie restriction group lost 7.6 kg versus 0.4 kg in controls (P < 0.001). Compared to controls, calorie restriction improved depressive symptoms, tension, general health, and sexual drive at month 24, as well as sleep duration at month 12 (all P < 0.05), with no adverse quality-of-life effects.
Martin CK, Bhapkar M, Pittas AG, et al. JAMA Intern Med, 2016. PMID 27136347
2016 / Randomized controlled trial
A randomized trial assigned 44 patients with metabolic syndrome to lifestyle advice alone or with 30 grams of milled flaxseed daily. Metabolic syndrome rates dropped by 82% in the flaxseed group compared to 50% in controls. The flaxseed group experienced greater reductions in insulin resistance (p < 0.001), body weight, waist circumference, and body mass index, although blood pressure showed no significant alterations.
Yari Z, Rahimlou M, Poustchi H, et al. Phytother Res, 2016. PMID 27151322
2016 / Randomized crossover trial
Twenty healthy nonobese men completed an fMRI food picture evaluation task after consuming control inulin or inulin-propionate ester in a randomized crossover design. Increasing colonic propionate reduced the blood oxygen level-dependent signal in the caudate and nucleus accumbens, with the caudate reduction driven specifically by a decreased response to high-energy food. These effects were accompanied by lower subjective appeal of high-energy food pictures and reduced ad libitum energy intake, without changes in plasma PYY, GLP-1, glucose, or insulin.
Byrne CS, Chambers ES, Alhabeeb H, et al. Am J Clin Nutr, 2016. PMID 27169834
2016 / Randomized controlled trial
In two randomized controlled trials, 55 overweight and obese adults consumed test meals containing varying mycoprotein amounts (44 g, 88 g, or 132 g) or isoenergetic chicken. High mycoprotein decreased subsequent ad libitum energy intake by 10% (280 kJ / 67 kcal, P=0.009) relative to chicken. All mycoprotein meals reduced postprandial insulin concentrations (incremental AUC drops of 8%, 12%, and 21%, P=0.004), without altering glucose, GLP-1, PYY, or energy expenditure.
Bottin JH, Swann JR, Cropp E, et al. Br J Nutr, 2016. PMID 27198187
2016 / Randomized crossover trial
Eleven healthy normal-weight women completed a crossover trial comparing two 14-day isoenergetic diets consumed in regular (6 meals daily) or irregular (3-9 meals daily) patterns. Regular meal timing produced a significantly greater thermic effect of food (P < 0.05) and reduced glucose incremental area under the curve following a test drink and selected meals. Participants also reported lower hunger and greater fullness ratings during the regular intervention.
Alhussain MH, Macdonald IA, Taylor MA Am J Clin Nutr, 2016. PMID 27305952
2016 / Randomized crossover trial
Eight overweight or obese men completed a randomized crossover trial comparing 24 hours of severe energy restriction (25% of energy needs) against energy balance (100%). Ad libitum energy intake did not differ between conditions on day 2 (15,251 kJ vs 14,946 kJ; P=0.623), day 3, or both days combined. Aside from higher post-breakfast NEFA, GIP, and fat oxidation, hormonal appetite markers and day 2 appetite ratings remained unchanged.
Clayton DJ, Creese M, Skidmore N, et al. Int J Obes (Lond), 2016. PMID 27339607
2016 / Randomized controlled trial and animal study
A randomized controlled trial in humans demonstrated that a moderate protein-restricted diet improved markers of metabolic health. In parallel animal experiments, mice provided a diet specifically low in branched-chain amino acids showed improvements in glucose tolerance and body composition comparable to whole protein restriction. These changes operated through distinct metabolic pathways, indicating that dietary amino acid composition directly influences metabolic function.
Fontana L, Cummings NE, Arriola Apelo SI, et al. Cell Rep, 2016. PMID 27346343
2016 / Inpatient sequential-diet feeding study
Seventeen overweight or obese men resided in metabolic wards and consumed a high-carbohydrate diet for four weeks, followed by four weeks on an isocaloric ketogenic diet. Chamber energy expenditure increased by 57 ± 13 kcal/d (P = 0.0004) and doubly labeled water expenditure rose by 151 ± 63 kcal/d (P = 0.03). However, loss of body fat slowed, and participants lost fat-free mass alongside higher protein utilization.
Hall KD, Chen KY, Guo J, et al. Am J Clin Nutr, 2016. PMID 27385608
2016 / 4-arm randomized controlled trial
A 12-month trial randomized 439 overweight/obese postmenopausal women to caloric restriction diet, aerobic exercise, combined diet + exercise, or control. Diet + exercise significantly reduced PAI-1 compared to control (-19.3% vs. +3.48%, P < 0.0001). Both the diet and combined arms showed significant reductions versus controls in PEDF (-9.20% and -9.90%, both P < 0.0001) and VEGF (-8.25%, P = 0.0005; -9.98%, P < 0.0001). Exercise alone produced no differences in any analyte versus control, while greater weight loss linearly correlated with larger biomarker reductions.
Duggan C, Tapsoba Jde D, Wang CY, et al. Cancer Res, 2016. PMID 27417562
2016 / Randomized, double-blind crossover trial
Six overweight/obese men underwent two experimental periods with endoscopically placed catheters for distal and proximal colonic infusions of sodium acetate (100 or 180 mmol/l) or placebo across fasting and postprandial conditions. Distal colonic 180 mmol/l acetate infusions significantly increased fasting fat oxidation (1.78±0.28 vs. -0.78±0.89 g fat 2 h-1, P=0.015), fasting PYY (P=0.01), and postprandial glucose and insulin levels (P<0.05) compared to placebo. Distal 100 mmol/l acetate tended to decrease fasting TNF-α (P=0.067). In contrast, proximal colonic acetate infusions had no observed effects on substrate metabolism, circulating hormones, or inflammatory markers.
van der Beek CM, Canfora EE, Lenaerts K, et al. Clin Sci (Lond), 2016. PMID 27439969
2016 / Randomized controlled crossover study and in vitro fermentations
Researchers developed inulin short-chain fatty acid esters to deliver propionate directly to the colon and tested them in vitro and in humans. In a randomized controlled crossover study, participants received 10 g/day of IPE-27, IPE-54, or inulin control for 7 days. In vivo, IPE-27 produced greater 13C recovery in breath CO2 than IPE-54 (64.9 vs. 24.9%, P = 0.001) and reduced energy intake during an ad libitum test meal compared with inulin (439.5 vs. 703.9 kcal, P = 0.025) and IPE-54 (439.5 vs. 659.3 kcal, P = 0.025). Intake with IPE-54 did not differ significantly from inulin control.
Polyviou T, MacDougall K, Chambers ES, et al. Aliment Pharmacol Ther, 2016. PMID 27464984
2016 / Intervention study (mice and humans)
Investigators studied the effects of dietary protein dilution (DPD) on metabolic health markers in mice and humans, as well as its mechanistic pathways in murine models. DPD increased serum markers of metabolic health in both mice and humans. In lean mice, DPD promoted metabolic inefficiency by increasing carbohydrate and fat oxidation, and in murine models of obesity, it prevented and curtailed impaired glucose homeostasis independently of obesity and food intake. The metabolic improvements required liver-derived FGF21, induced by liver-integrated stress response-driven NUPR1 triggered by insufficiency of select nonessential amino acids.
Maida A, Zota A, Sjøberg KA, et al. J Clin Invest, 2016. PMID 27548521
2016 / Randomized controlled experiment
Seventy healthy, mostly lean men and women completed an exercise bout (estimated energy expenditure 120 kcal) and were informed that they had expended either 50 kcal or 265 kcal. Participants then received an ad libitum test meal containing orange juice, tortilla chips, and chocolate chip cookies. Greater energy intake, primarily driven by chocolate chip cookie consumption (p = 0.015), occurred in the 265 kcal group. Hunger ratings were significantly lower in the 265 kcal information group compared with the 50 kcal group after the test meal (p = 0.035), but not immediately after exercise.
McCaig DC, Hawkins LA, Rogers PJ Appetite, 2016. PMID 27554186
2016 / Randomized controlled trial
A randomized pilot trial assigned 26 adults with obesity to 8 weeks of zero-calorie alternate-day fasting or daily calorie restriction (-400 kcal/day). Weight loss did not differ significantly between groups at 8 weeks (-8.2 ± 0.9 kg for fasting vs -7.1 ± 1.0 kg for restriction), nor were there differences in lipids, body composition, or insulin sensitivity. After 24 weeks of unsupervised follow-up, weight regain was similar between groups.
Catenacci VA, Pan Z, Ostendorf D, et al. Obesity (Silver Spring), 2016. PMID 27569118
2016 / Randomized controlled trial
In a 12-week trial of 80 overweight and obese women in a weight-loss program, 69 completed allocating their main energy intake to lunch or dinner. The lunch group achieved greater reductions in weight (-5.85 kg vs. -4.35 kg; P = 0.003), body mass index (P = 0.003), fasting insulin (P < 0.001), and insulin resistance (P = 0.001) than the dinner group. Fasting glucose and lipid profiles did not differ between groups.
Madjd A, Taylor MA, Delavari A, et al. Am J Clin Nutr, 2016. PMID 27581472
2016 / Clinical trial
A clinical trial examined postmenopausal women with obesity undergoing approximately 10% weight loss on hypocaloric diets containing either 0.8 g or 1.2 g protein/kg/day. The higher-protein diet reduced lean tissue loss by roughly 45%. However, higher protein intake also eliminated the weight-loss-induced gains in muscle insulin signaling and insulin-stimulated glucose uptake, while preventing cellular adaptations in oxidative stress pathways.
Smith GI, Yoshino J, Kelly SC, et al. Cell Rep, 2016. PMID 27732859